Certainty in the Ever-Changing Pharmacovigilance Landscape
Managing the safety risks of your medical therapies/products is critical throughout the duration of their lifecycle. We provide you with the certainty that your pharmacovigilance needs are being addressed in a comprehensive and proficient manner.
Veristat supports successful pre-approval and post-market pharmacovigilance (PV) and Medical Information (MI) expertise for pharmaceutical drugs (brand and generic), biologics, radiopharmaceutical drugs, natural health products, and medical devices.
Under the continued leadership of Rita Cassola and Agnes Jankowicz, our experienced experts deliver pharmacovigilance services at all levels, including specialists, senior consultants, strategists, and safety physicians.
With the acquisition of SFL (Solutions for Life Sciences), Veristat expands its Pharmacovigilance expertise into Europe.
Tailored PV Solutions to Reduce Risk
Our team of highly dedicated and experience PV professionals ensures the fulfillment of your regulatory requirements through sound processes and efficient systems.
PVG Systems Set-Up
PVG expertise to set-up and maintain your PVG/safety surveillance system.
Audits & Inspections
Always be PVG inspection ready to ensure no findings at your next audit.
ICSR & Aggregate Reports
The PVG expertise to prepare both individual and aggregate drug safety reporting to the regulatory agencies in a timely and accurate manner.
Support the development of risk minimization measures with an implementation scheme, specific tool recommendations, and an evaluation strategy.